Global Peptide Therapeutics Market
Peptides are defined as selective and efficacious signaling molecules which bind to specific cell surface receptors to trigger intracellular effects. Peptides are gaining popularity as clinical therapeutics. Peptides are highly tunable molecules that can be used to achieve desirable biocompatibility & biodegradability with simultaneously selective & potent therapeutic effects.
Market Drivers
The increase in prevalence of metabolic diseases & cardiovascular disorders is expected to propel the global peptide therapeutics market growth over the forecast period. For instance, as per the American Heart Association’s Heart Disease & Stroke Statistics 2018, approx 92.1 million adults in the United States are suffering from some form of CVD or the after-effects of stroke. Furthermore, the increase in healthcare expenditure is also expected to boost the global peptide therapeutics market growth. For instance, as per the information of Centers for Medicare & Medicaid Services, health spending the United States is anticipated to grow at an average rate of 5.5% per year for 2018-2027 and to reach around US$ 6.0 trillion, by 2030.
The market growth is associated with increasing investments in drug discovery, research and development activities in peptide therapeutics are mainly focused on the development of drugs about oncology followed by metabolic disorders, infectious diseases, and diabetes. The presence of a strong product pipeline in this segment is also one of the prominent factors anticipated to drive the peptide therapeutics market growth during this forecast period.
Market Restraints
Poor Chemical & physical stability and a short circulating plasma half-life of naturally occurring peptides are expected to hamper the global peptide therapeutics market growth. Also, the presence of stringent safety regulations may restraint the market growth.
Market Segmentation
The Global Peptide Therapeutics Market is segmented into type such as Generic, and Branded, by application such as Gastrointestinal Disorders, Neurological Disorders, Metabolic Disorders, Cancer, and others. Further, market is segmented into route of administration such as Oral, Parental, and Others.
Also, the Global Peptide Therapeutics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Regional Analysis
The North America region is expected to held dominant position in the overall peptide therapeutics market, throughout the forecast period, due to some factors such as the increase in awareness levels relating to peptide therapeutics, products, growing necessity for diagnostics in cancer & other diseases. The rising R & D activities expenditure by government & key players is also expected to drive the peptide therapeutics market in this region. Also, the APAC is projected to register considerable growth throughout the forecast period due to high untapped opportunities, growing base of companies providing outsourcing services, low cost of raw material, and growing investments in research and development sector.
Key Players
Various key players are listed in this report such as Teva Pharmaceutical Industries Ltd, Amgen Inc, PeptiDream Inc, Novartis AG, Pfizer Inc, CirclePharma, Inc., Encycle Therapeutics, Inc., Sanofi S.A., Eli Lilly and Company, Novo Nordisk A/S, Takeda Pharmaceuticals Co. Ltd., etc.
Market Taxonomy
By Type
By Application
By Route of Administration
By Region
Key Questions Addressed by the Report
Global Peptide Therapeutics Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Peptide Therapeutics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Peptide Therapeutics Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Peptide Therapeutics Market Share Analysis, By Type
5.3 Global Peptide Therapeutics Market Size and Forecast, By Type
5.3.1 Generic
5.3.2. Branded
6 Global Peptide Therapeutics Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Peptide Therapeutics Market Share Analysis, By Application
6.3 Global Peptide Therapeutics Market Size and Forecast, By Application
6.3. 1.Gastrointestinal Disorders
6.3.2. Neurological Disorders
6.3.3. Metabolic Disorders
6.3.4. Cancer
6.3.5. Others
7 Global Peptide Therapeutics Market, By Route of Administration
7.1 Y-o-Y Growth Comparison, By Route of Administration
7.2 Global Peptide Therapeutics Market Share Analysis, By Route of Administration
7.3 Global Peptide Therapeutics Market Size and Forecast, By Route of Administration
7.3. 1 Oral
7.3.2. Parental
7.3.3. Others
8 Global Peptide Therapeutics Market, By Region
8.1 Global Peptide Therapeutics Market Share Analysis, By Region
8.2 Global Peptide Therapeutics Market Share Analysis, By Region
8.3 Global Peptide Therapeutics Market Size and Forecast, By Region
9 North America Peptide Therapeutics Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Peptide Therapeutics Market Share Analysis, By Type
9.3 North America Peptide Therapeutics Market Size and Forecast, By Application
9.4 North America Peptide Therapeutics Market Size and Forecast, By Route of Administration
9.5 North America Peptide Therapeutics Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 EuropePeptide Therapeutics Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Peptide Therapeutics Market Share Analysis, By Type
10.3 Europe Peptide Therapeutics Market Size and Forecast, By Application
10.4 Europe Peptide Therapeutics Market Size and Forecast, By Route of Administration
10.5 Europe Peptide Therapeutics Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Peptide Therapeutics Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Peptide Therapeutics Market Share Analysis, By Type
11.3 Asia Pacific Peptide Therapeutics Market Size and Forecast, By Application
11.4 Asia Pacific Peptide Therapeutics Market Size and Forecast, By Route of Administration
11.5 Asia Pacific Peptide Therapeutics Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Peptide Therapeutics Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Peptide Therapeutics Market Share Analysis, By Type
12.3 Latin America Peptide Therapeutics Market Size and Forecast, By Application
12.4 Latin America Peptide Therapeutics Market Size and Forecast, By Route of Administration
12.5 Latin America Peptide Therapeutics Market Size and Forecast, Country
13Middle East Peptide Therapeutics Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Peptide Therapeutics Market Share Analysis, By Type
13.3 Middle East Peptide Therapeutics Market Size and Forecast, By Application
13.4 Middle East Peptide Therapeutics Market Size and Forecast, By Route of Administration
13.5 Middle East Peptide Therapeutics Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Teva Pharmaceutical Industries Ltd
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Amgen Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. PeptiDream Inc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Novartis AG
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Pfizer Inc
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 CirclePharma, Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Encycle Therapeutics, Inc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Sanofi S.A
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Eli Lilly and Company
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Novo Nordisk A/S
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
15.11 Takeda Pharmaceuticals Co. Ltd
15.11.1 Overview
15.11.2 Offerings
15.11.3 Key Financials
15.11.4 Business Segment & Geographic Overview
15.11.5 Key Market Developments
15.11.6 Key Strategies
